Course Faculty
Course Director
Gerardo Colon-Otero, M.D.
Chair, Division of Hematology-Oncology
Mayo Clinic Florida
Course Co-directors
| Steven R. Alberts M.D. |
William J. Maples, M.D. |
| Thomas M. Habermann, M.D. |
Michael Menefee, M.D. |
| Paul Haluska Jr., M.D. PhD |
Edith A. Perez, M.D. |
| Mark R. Litzow, M.D. |
Winston Tan, M.D. |
Distinguished Guest Faculty
Robert J. Amdur, M.D.
Professor, Department of Radiation Oncology
University of Florida
Gainesville, FL
Janice Dutcher, M.D.
Professor of Medicine
Our Lady of Mercy Hospital Cancer Center
Bronx, NY
G. Douglas Letson, M.D.
Professor of Medicine
H. Lee Moffitt Cancer Center
Tampa, FL
Alan F. List, M.D.
Professor of Medicine
H. Lee Moffitt Cancer Center
Tampa, FL
Alejandra Perez, M.D.
Director, Breast Cancer Centers
Memorial Health Care System
Hollywood, FL
Fauzia Rana, M.D.
University of Florida - Shands
Jacksonville, FL
Deborah Toppmeyer, M.D.
UMDNJ, Cancer Institute of New Jersey
New Brunswick, NJ
Mayo Clinic Faculty
| Horacio J. Asbun, M.D. |
Charles Loprinzi, M.D. |
| Jaime Bakkum-Gamez, M.D. |
Sarah McLaughlin, M.D. |
| Charles Erlichman, M.D. |
William J. Maples, M.D. |
| Axel Grothey, M.D. |
Michael E. Menefee, M.D. |
| Thomas M. Habermann, M.D. |
Ruben Mesa, M.D. |
| Paul Haluska, M.D. PhD |
Justin Nguyen, M.D. |
| Kurt Jaeckle, M.D. |
Ricardo Paz-Fumagalli, M.D. |
| Jeffrey Karnes, M.D. |
Edith A. Perez, M.D. |
| Shaji Kumar, M.D. |
Fernando Quevedo, M.D. |
| Aminah Jatoi, M.D. |
Vivek Roy, M.D. |
| Elizabeth A. Johnson, M.D. |
Tait Shanafelt, M.D. |
| Manish Kohli, M.D. |
Robert A. Smallridge, M.D |
| George Kim, M.D. |
Lawrence A. Solberg, PhD, M.D. |
| Mark R. Litzow, M.D. |
Laura Vallow, M.D. |
Faculty Disclosure
As a provider accredited by ACCME, Mayo Clinic College of Medicine (Mayo School of CPD) must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also will disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of these relevant financial relationships will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentation.
|
